Wenliang Dong


Wenliang is Chief Operational Officer at ORCA Therapeutics BV. He has managed internal and external teams in the development of ORCA’s lead product, ORCA-010. As COO he manages all operational activities related to the development of ORCA’s technology from R&D to clinical development.

Wenliang has worked at Sanquin Plasma Products BV as member of the management team of Pharmaceutical services. He holds a PhD in Medical Microbiology from the university of Leiden. During his PhD he has worked at the German Cancer Research Center in Heidelberg (Germany) and at the International Agency for Research on Cancer in Lyon (France).